Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes
A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.
Patient Care Team
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes (VitalCare - Guardian Version 2)|
- Improvement of outcome for patients after implementing the IGS [ Time Frame: 15 months ] [ Designated as safety issue: Yes ]Does the IGS significantly increase positive outcomes for deteriorating patients after referral to the RRT/ACT as measured by the MAELOR score
- Early detection of patient deterioration [ Time Frame: 15 months ] [ Designated as safety issue: Yes ]Does the IGS detect patient deterioration earlier and therefore prevent or shorten periods of severe illness.
- Daily workload for the ward's personnel [ Time Frame: 15 months ] [ Designated as safety issue: No ]Does the IGS reduce the daily workload related to patient surveillance for the general ward personnel.
- Level of satisfaction [ Time Frame: 15 months ] [ Designated as safety issue: No ]Do Nurses and Doctors express a higher level of satisfaction with the IGS in place than with their current paper-based surveillance.
|Study Start Date:||October 2012|
|Estimated Study Completion Date:||April 2015|
|Estimated Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
RRT calls prior to IGS use
Patients who triggered ACT/RRT calls prior to the installation of the IGS (Intellivue Guardian System)
RRT calls during IGS use
Patients who triggered ACT/RRT calls after the installation of IGS. All patients on the study ward receive the same care in both groups. The only difference is the system used to collect vital signs and to inform the staff about patient deteriorations. In Group 2, the IGS (FDA approved and CE marked) is the vital signs collection and information system.
The purpose of this study is to assess if the Philips IntelliVue Guardian Solution (IGS) with all its components can significantly improve clinical outcomes for deteriorating patients on a general medical ward prior and after referral to the hospitals' Acute Care Team (ACT). Further, to provide evidence that the Philips IGS assists to increase the efficiency of a hospital's Early Warning Scoring process (afferent and efferent arm of the escalation system).
The introduction of such an intelligent automated system offers a unique opportunity to address the breakdown in the chain of prevention by strengthening the reliability of calls-for-help to responders through a technical solution with the potential for a more timely escalation where appropriate.
In this study the hospital's Standard of Care protocol for the monitoring of vital signs (including timing, vital signs collected and escalation instructions) will be implemented in a commercially available intelligent automatic monitoring and notification system. No investigational procedures or devices are associated with this protocol.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01692847
|Contact: Bernd P Duller, MD||+49 160 email@example.com|
|Ysbyty Gwynedd Hospital||Recruiting|
|Bangor, Penrhosgarnedd, United Kingdom, LL572PW|
|Principal Investigator:||Christian P Subbe, MD||Bangor University|